We performed an additional more stringent analysis by assessing whether individual samples had positive antibody responses for Cas9 or tetanus toxoid defined by an AUC greater than 3 standard deviations above the mean AUC for the HSA negative control (from data shown in Fig. 1B). The gene discussed is ALB; the disease is tetanus.